SAN DIEGO--(BUSINESS WIRE)-- DexCom, Inc. (NASDAQ:DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, announced today that Stelo, the first over-the-counter ...

Join the event trusted by enterprise leaders for nearly two decades. VB Transform brings together the people building real enterprise AI strategy. Learn more About one in three Americans, or 125 ...

Credit: Dexcom. The Dexcom Stelo Glucose Biosensor System is an integral CGM intended for individuals 18 years of age and older with or without diabetes who are not on insulin. The Food and Drug ...

After getting the green light from the FDA back in March, Dexcom today launched its first over-the-counter wearable continuous glucose biosensor, Stelo, in the U.S. market. The device is now available ...

Credit: Dexcom. Stelo is an integrated CGM that continuously measures, records, analyzes, and displays glucose values in individuals 18 years of age and older who are not on insulin. Dexcom’s Stelo ...

DexCom Inc. DXCM recently announced the FDA clearance of its Stelo glucose biosensor, available over-the-counter to consumers without a prescription. The company’s latest Continuous Glucose Monitoring ...

I’ve always considered myself a somewhat healthy person, especially after I gave up smoking and vaping a few years ago. Unfortunately, that proved incorrect. Three years ago, I had a near-constant ...

This week, Dexcom became the first medical device company to integrate generative AI into a continuous glucose monitor. The company added generative AI to its Stelo glucose monitor, which it began ...

Please provide your email address to receive an email when new articles are posted on . The Dexcom Stelo Glucose Biosensor System was cleared for over-the-counter sale on March 5. The CGM was approved ...